Association of Mediterranean diet with survival after breast cancer diagnosis in women from nine European countries: results from the EPIC cohort study
Carlota Castro-Espin,Catalina Bonet,Marta Crous-Bou,Núria Nadal-Zaragoza,Anne Tjønneland,Lene Mellemkjær,Mariem Hajji-Louati,Thérèse Truong,Verena Katzke,Charlotte Le Cornet,Matthias B Schulze,Franziska Jannasch,Giovanna Masala,Sabina Sieri,Salvatore Panico,Chiara Di Girolamo,Guri Skeie,Kristin Benjaminsen Borch,Karina Standahl Olsen,Maria-Jose Sánchez,Pilar Amiano,María-Dolores Chirlaque,Marcela Guevara,Malin Sund,Stina Bodén,Marc J Gunter,Esther M Gonzalez-Gil,Elisabete Weiderpass,Inmaculada Aguilera-Buenosvinos,Kostas K Tsilidis,Alicia K Heath,Dagfinn Aune,Laure Dossus,Antonio Agudo
DOI: https://doi.org/10.1186/s12916-023-02934-3
2023-06-26
Abstract:Background: The Mediterranean diet has been associated with lower risk of breast cancer (BC) but evidence from prospective studies on the role of Mediterranean diet on BC survival remains sparse and conflicting. We aimed to investigate whether adherence to Mediterranean diet prior to diagnosis is associated with overall and BC-specific mortality. Methods: A total of 13,270 incident breast cancer cases were identified from an initial sample of 318,686 women in 9 countries from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Adherence to Mediterranean diet was estimated through the adapted relative Mediterranean diet (arMED), a 16-point score that includes 8 key components of the Mediterranean diet and excludes alcohol. The degree of adherence to arMED was classified as low (score 0-5), medium (score 6-8), and high (score 9-16). Multivariable Cox proportional hazards models were used to analyze the association between the arMED score and overall mortality, and Fine-Gray competing risks models were applied for BC-specific mortality. Results: After a mean follow-up of 8.6 years from diagnosis, 2340 women died, including 1475 from breast cancer. Among all BC survivors, low compared to medium adherence to arMED score was associated with a 13% higher risk of all-cause mortality (HR 1.13, 95%CI 1.01-1.26). High compared to medium adherence to arMED showed a non-statistically significant association (HR 0.94; 95% CI 0.84-1.05). With no statistically significant departures from linearity, on a continuous scale, a 3-unit increase in the arMED score was associated with an 8% reduced risk of overall mortality (HR3-unit 0.92, 95% CI: 0.87-0.97). This result sustained when restricted to postmenopausal women and was stronger among metastatic BC cases (HR3-unit 0.81, 95% CI: 0.72-0.91). Conclusions: Consuming a Mediterranean diet before BC diagnosis may improve long-term prognosis, particularly after menopause and in cases of metastatic breast cancer. Well-designed dietary interventions are needed to confirm these findings and define specific dietary recommendations.